Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

MyDiabetesMyWay

MyDiabetesMyWay is an affordable, scalable, data-driven self-management platform for people with diabetes shown to improve health outcome sand provide cost savings (ROI ~5:1). MyDiabetes Clinical is a clinician platform supporting individual and population level evidence-based management, risk profiling and analytics.

  • Virtual care
  • Self-management
MyDiabetesMyWay logo

MyDiabetesMyWay (MDMW) is a web-based platform/ smartphone app for people with diabetes, tethered to the healthcare system. It offers multimedia education, structured e-learning (QISMET approved), NHS health-record access, integration with home-recorded data, remote communication and highly tailored advice/ reports. MDMW has run nationally, since 2008, across NHS Scotland, and is implemented in 20% of NHS England through MyWay Digital Health. MDMW has more than 60,000 registrants (full data access) and more than 500,000 unique users (education platform); utilising over 250 multimedia educational resources, including >100 non-english language resources, and 7 times fully (QISMET) accredited structured education e-learning courses for type 1, type 2, gestational diabetes and diabetes prevention.

MDMW integrates with NHS records through linkages with GP, other NHS IT systems, and home-recorded data through device integrations (blood glucose, activity data) and manual data input (including blood pressure/ weight). MDMW enables remote communication with health care providers (secure messaging) and drives highly tailored advice and reports (data-algorithms). MDMW improves health outcomes (HbA1C, weight and blood pressure) with significant cost savings (ROI~ 5:1).

MyWay Digital Health has developed a complimentary clinician and population analytics solution (MyDiabetes Clinical), a diabetes electronic health record, remote communication platform encompassing clinician-facing decision support (improving guideline adherence), national KPI tracking, local audit functionality and predictive analytics for diabetes complications, health deterioration, diagnosis at individual/ population level.

MDMW awards include European e-health adopters (2017), Diabetes UK self-management (2015), Quality in Diabetes Care (2013) awards, Emerging Digital Health Company of the Year (Scotland Is) (2019). Wake (CEO) is a 2019 National Women in Innovation Award winner and NHS Innovation Accelerator fellow. MWDH have led Innovate UK SBRI/ Digital Health Catalysts/ Test-bed Projects (>£2.5m funding).

Impact

MyWay Diabetes systems are increasingly relevant given the disproportionate impact of COVID-19 on people with diabetes who constitute 40% of deaths. Severity of COVID-19 outcomes is linked closely to obesity/ poor diabetes/risk factor control. There is an urgent need for solutions to reduce face-to-face contact/ improve outcomes through remote patient-clinician communication, online education/ self-management. MyDiabetes Clinical can further risk-stratify populations enabling triage of those in need, given limited resources and risk associated with clinical contact.